Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

Beijing Hotgen Biotech Revenue

Beijing Hotgen Biotech had revenue of 93.24M CNY in the quarter ending March 31, 2025, a decrease of -19.71%. This brings the company's revenue in the last twelve months to 488.02M, up 5.86% year-over-year. In the year 2024, Beijing Hotgen Biotech had annual revenue of 510.90M, down -6.74%.

• Revenue (ttm): 488.02M
• Revenue Growth: +5.86%
• P/S Ratio: 36.22
• Revenue / Employee: 540.44K
• Employees: 903
• Market Cap: 17.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	510.90M	-36.94M	-6.74%
Dec 31, 2023	547.84M	-3.01B	-84.60%
Dec 31, 2022	3.56B	-1.81B	-33.76%
Dec 31, 2021	5.37B	4.86B	945.54%
Dec 31, 2020	513.53M	303.12M	144.06%